Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Forecast Data Period | 2026 - 2031 |
| Historical Data Period | 2020 - 2024 |
| Growth Rate | 6.11% CAGR |
| Market Concentration | High |
Major Players *Disclaimer: Major Players sorted in no particular order Image ? Â鶹ÊÓƵ. Reuse requires attribution under CC BY 4.0. | |
UAE General Surgical Devices Market Analysis by Â鶹ÊÓƵ
The UAE general surgical devices market size is expected to register a CAGR of 6.11% during the forecast period.
The COVID-19 pandemic impacted the market significantly. The market was adversely impacted during the initial phase of the pandemic due to the lockdowns and shutdowns. However, the United Arab Emirates government continued normal operations in the healthcare system following proper regulations and restrictions. This created opportunities for various surgical procedures. Additionally, due to the increasing number of hospital admissions and increasing cases of obesity in the country, bariatric surgeries were allowed in the United Arab Emirates. For instance, according to a study published in June 2022 in Bariatric Surgical Practice and Patient Care, it has been observed that bariatric procedures in the country continued even during the peak phase of the pandemic, and some of the healthcare facilities were approved as COVID-19-free facilities by the United Arab Emirates government regulations to perform such surgeries. Thus, the ongoing surgical procedures during the pandemic have created a demand for surgical devices, which has impacted the market's growth. Moreover, the growing number of surgeries performed in the country after the COVID-19 pandemic as well as the device launches have increased the demand for technologically advanced surgical devices, and the studied market is expected to regain its full potential after the pandemic in the next two to three years.
The general surgical devices market is growing because of things like more people wanting minimally invasive surgeries, more injuries and accidents, and more money being spent on health care in the country.
The rising number of road traffic accidents and injuries among the target population is expected to increase the demand for surgical procedures, which in turn is anticipated to fuel market growth over the forecast period. For instance, as per an article published by NCBI in December 2021, it has been observed that the number of traffic fatalities has increased by 20% in the United Arab Emirates in 2021 as compared to the previous year. Also, as per the data published by the United Arab Emirates Road Safety in June 2022, it has been observed that 3,488 crashes were recorded in the United Arab Emirates in 2021, as compared to 2,931 in 2020, including 1,031 collisions and 548 accidents, as compared to 816 collisions and 492 accidents in 2020. Thus, the increasing number of road accidents and road injury cases raises the demand for emergency surgical procedures, which is expected to increase the demand for efficient surgical devices. This is anticipated to fuel market growth.
The country is improving its surgical facilities by building new, state-of-the-art surgical centers that concentrate on using cutting-edge surgical and medical technology for patient care. For instance, in August 2022, Dubai Hospital opened a new outpatient building with 128 specialized clinics equipped with the latest technology, with an investment of USD 48 million. Also, in May 2022, Aster Hospitals United Arab Emirates opened its first full-fledged oncology section at its branch in Al Qusais, Dubai, in response to a significant increase in demand for cancer screenings and treatment. The new facility initially focuses on surgical and medical oncology and offers expert cancer care with an emphasis on integrative treatment. So, these changes and improvements in hospitals lead to a high demand for surgical tools in the country, which helps the market grow.
Furthermore, the growing acceptance of minimally invasive, robotic, and computer-assisted surgery is likely to drive market growth over the forecast period. For instance, in May 2022, Dubai Hospital launched the Da Vinci Xi Surgical Robot for performing robotic-assisted minimally invasive surgeries. The robot has advanced laparoscopic surgical technologies that help improve services in the United Arab Emirates for both general surgery and laparoscopic surgery.
Moreover, the increasing demand for minimally invasive surgeries and the emerging technological advancements in surgical products and their growing adoption are also contributing to the market's growth. For instance, in June 2022, the Advanced Microfluidics and Microdevices Laboratory (AMMLab) at NYU Abu Dhabi (NYUAD) developed a simple but efficient method for on-demand tactile sensing in minimally invasive surgery. The new tool is a laparoscopic grasper with an off-the-shelf sensor built in. This sensor helps sense tissues during an operation.
Therefore, owing to the abovementioned factors, the market under study is expected to witness growth. But strict government rules and bad ways of paying for surgical devices are likely to slow the growth of the market for general surgical devices over the next few years.
Note: Market size and forecast figures in this report are generated using Â鶹ÊÓƵ¡¯s proprietary estimation framework, updated with the latest available data and insights as of 2026.
UAE General Surgical Devices Market Trends and Insights
Cardiology Segment is Anticipated to Witness Growth Over the Forecast Period
The cardiology segment is expected to witness significant growth in the general surgical devices market in the United Arab Emirates over the forecast period owing to factors such as the rising prevalence of cardiovascular diseases such as stroke, hypertension, and heart attack and their associated risk factors.
In addition, the presence of well-established healthcare infrastructure in the country also increases the demand for advanced surgical devices, thereby propelling segment growth. For instance, as per the data published by the ITA in July 2022, the United Arab Emirates is one of the most economically developed and diversified markets with a strong healthcare infrastructure. In addition, as per the same source, the government approved a federal budget of USD 15.8 billion (AED 58.931 billion) for public spending, of which 8.4% is dedicated to healthcare.
Cardiovascular disease (CVD) is the major cause of mortality in the country. For instance, as per an article published in the American Journal of Preventive Cardiology in December 2021, it has been observed that the United Arab Emirates has the second-highest cardiovascular mortality rate after Saudi Arabia and is higher than the average for Gulf Cooperation Council (GCC) nations. This is anticipated to increase the demand for cardiovascular surgeries, thereby boosting the growth of cardiology devices over the forecast period.
Additionally, according to the 2022 statistics published by the IDF, about 0.99 million people were living with diabetes in 2021 in the United Arab Emirates, and this number is projected to double by 2050. Thus, the expected increase in the diabetic population in the country may lead to a rise in cardiovascular complications, which is anticipated to boost the demand for surgeries, hence propelling the market's growth.
Similarly, as per a meta-analysis study published in December 2021, it has been observed that the combined prevalence of hypertension ranges between 20 and 35% in the country. In addition, as per the same source, the prevalence of hypertension was higher in Dubai than in the Abu Dhabi region. Thus, the elevated blood pressure in the population causes the left ventricle to thicken, which increases the risk of heart attack and cardiac failure. This is expected to augment segment growth over the forecast period.
Furthermore, the rising company activities and increasing focus on the adoption of various business strategies such as collaboration, partnerships, and others to develop advanced handheld devices for managing cardiovascular conditions This is also expected to drive segment growth over the forecast period. For instance, in March 2022, BioIntellisense, Inc. entered into a strategic collaboration with Mubadala Health to develop remote care technologies to drive clinical workflow efficiencies, unlock data-driven clinical insights, and deliver a personalized care experience. This collaboration with Mubadala Health offers a tremendous opportunity to apply the BioSticker and BioButton wearable medical devices in a variety of healthcare settings, simplify early detection, and provide care teams with individualized clinical intelligence that enables proactive, well-informed interventions.
So, the studied segment is likely to grow over the next few years due to the factors mentioned above, such as the growing number of cardiovascular diseases and the factors that go with them, as well as the growth of company activities.
Laparoscopic Devices Segment is Expected to Have the Significant Market Share Over the Forecast Period
The laparoscopic devices segment is expected to witness healthy growth in the general surgical device market over the forecast period owing to factors such as the rising prevalence of chronic diseases, increasing technological advancements, and rising demand for minimally invasive surgical procedures.
The rising burden of cancer, liver diseases, obesity, and others is the key factor driving the need for surgeries, hence propelling the demand for laparoscopic devices. For instance, according to the GLOBOCAN report, the estimated number of new breast cancer cases in the United Arab Emirates (UAE) is projected to reach 2,306 by 2040. As per the same source, about 2,306 new breast cancer cases are expected to be diagnosed in the United Arab Emirates by 2040.
Additionally, according to an article published in July 2021, about 372,000 people are projected to develop non-alcoholic fatty liver disease (NAFLD) in the United Arab Emirates by 2030. In addition, as per the same source, the prevalence of NAFLD was expected to rise by 87% by 2030 in the UAE. Thus, the expected increase in the population suffering from NAFLD is expected to increase the demand for laparoscopic surgeries, which in turn is anticipated to propel the demand for laparoscopic devices and laparoscopes, hence boosting segment growth.
The growing demand for minimally invasive surgeries (MIS) also increased market growth, as they cause less post-operative pain and patients receive smaller dosages of painkillers. As only minimal cuts or stitches are involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently. Also, the advantages of MIS over traditional open surgeries include producing a better and magnified image of the organs or body parts being operated on and higher precision due to video-assisted equipment.
Furthermore, the rising technological advancements and emerging trends of robotic surgery by surgeons during complex surgeries are expected to increase the market's growth over the forecast period. For instance, in October 2022, Sheikh Shakhbout Medical City (SSMC) performed its first robot-assisted gynecological surgery to treat abdominal pain in a patient due to a large pelvic mass on the left ovary. Also, in June 2022, Muna Kishwai performed robotic surgery to perform total and supra-cervical hysterectomies, cure uterine prolapse, and remove fibroids at a government-run hospital in the UAE.
Therefore, owing to factors such as the rising burden of chronic diseases, the increasing advantages of minimally invasive surgeries, and the increasing adoption of robotic and computerized surgeries in the country, the studied segment is expected to grow over the forecast period.
Regulatory Landscape
General surgical devices in the United Arab Emirates are regulated at the federal level under the Emirates Drug Establishment (EDE) framework, anchored by Federal Decree-Law No. (38) of 2024 on medical products and the pharmacy profession, which took effect on January 2, 2025. The decree-law broadens the medical device definition to include software and AI-based technology and wearables when they achieve their intended purpose without pharmacological, immunological, or metabolic action, bringing more digital and connected surgical technologies into formal registration and oversight.
Operationally, the market has been moving toward EDE-led processes, with EDE assuming responsibility for medical device marketing authorizations and import and export permits as of December 29, 2025. Market access typically depends on having an appropriately licensed local entity (such as a marketing office or medical warehouse) and documented quality and vigilance systems, and distribution controls can restrict professional-use devices from being supplied directly to patients. This affects how suppliers set up importer-of-record, warehousing, and channel models.
Competitive Landscape
The general surgical devices market in the United Arab Emirates is competitive and consists of several market players. These players are focusing on research and development to create stable and safe devices for surgical procedures. The market has been noticing technological developments on a large scale for the past decade. Medtronic PLC, Stryker Corporation, B. Braun SE, Smith & Nephew, Olympus Corporations, and 3M are among the market participants.
UAE General Surgical Devices Industry Leaders
Smith + Nephew
Olympus Corporations
Stryker Corporation
Medtronic PLC
B. Braun SE
- *Disclaimer: Major Players sorted in no particular order
Market Opportunities and Future Outlook
Operating-room digitization creates a demand for suppliers that can connect laparoscopic and general surgery devices with data platforms, analytics, and workflow tools. In May 2026, the Department of Health, Abu Dhabi and Johnson & Johnson launched an intelligent surgical network across multiple provider groups, including Cleveland Clinic Abu Dhabi, PureHealth, Mediclinic Group, and NMC Healthcare. The network uses a shared open digital ecosystem in operating rooms, which supports demand for compatible device portfolios, service enablement, and standardized training as hospitals expand minimally invasive and complex procedures.
Healthcare buildouts and industrial localization programs are also widening procurement and partnership pathways beyond traditional import-only models. Federal and emirate-level commitments for new hospital facilities and specialty centers for the 2024-2028 period, along with industrial platform development such as KEZAD, support opportunities for local or regional assembly, sterile processing support, and faster technical service footprints for surgical devices. With the shift to EDE-led federal regulation and portal-based processes, manufacturers and distributors that invest in UAE-based regulatory, service, and training capabilities have a clearer path to meeting local compliance requirements, including licensed warehouses, marketing authorization holders, and quality systems.
Recent Industry Developments
- May 2026: Olympus announced an exclusive global distribution agreement with EndoRobotics Co., Ltd. for robot-assisted technologies that will be incorporated into its EndoTherapy portfolio. The partnership expands Olympus participation in robot-assisted procedural workflows that overlap with minimally invasive surgery and endoscopic intervention. It also supports a broader procedural offering for hospitals beyond core visualization and instrumentation.
- December 2025: Olympus inaugurated its Middle East, Turkiye and Africa (META) Service Training Centre at Dubai Science Park with an investment of AED 3.7 million (USD 1 million). The UAE-based hub supports partners across more than 33 countries and strengthens local access to technical training and service readiness for surgical and endoscopy systems. A larger in-country service capability can reduce downtime and improve uptake of advanced systems at high-throughput hospitals.
- January 2024: Emirates Drug Establishment (EDE) continued advancing the federal transition toward centralized medical product regulation that later culminated in Decree-Law No. (38) of 2024 and the migration of device authorization workflows. The evolving framework required manufacturers and distributors to align licensing, quality systems, and import permit practices with a single federal authority. This regulatory consolidation affected how suppliers manage UAE market entry, local representation, and distribution compliance.
Research Methodology Framework and Report Scope
Market Definition and Coverage
For this methodology, the UAE general surgical devices market is defined as the value of devices used during surgical procedures in the UAE across hospital and day surgery settings, measured at the manufacturer level (net of discounts where visible) and expressed in USD.
Scope exclusions: We exclude services such as maintenance contracts, procedure fees, and standalone capital equipment not sold as a general surgical device.
Segmentation Overview
- By Product
- Handheld Devices
- Laproscopic Devices
- Electro Surgical Devices
- Wound Closure Devices
- Trocars and Access Devices
- Other Products
- By Application
- Cardiology
- Orthopedic
- Neurology
- Gynecology and Urology
- Other Applications
Data Sources, Market Sizing, and Validation
Desk Research
Desk research was used to build the basic demand context and to keep the market model anchored to what is measurable in the UAE. We referred to public sources such as Ministry of Health and Prevention releases, Dubai Health Authority updates, and statistics from the Federal Competitiveness and Statistics Centre, which help us understand procedure growth, facility expansion, and care delivery shifts. Trade data indicators were also reviewed through UAE Federal Customs Authority type publications and UN Comtrade type datasets, mainly to sanity-check the direction of device inflows for relevant HS codes.
On the supply and pricing side, we screened company annual reports, investor decks, product catalogs, and regulatory or tender announcements published on official portals, then matched them with pricing signals seen in publicly available procurement notes. Where needed, paid subscriptions for company financials and shipment-level import or export databases were used to cross-check revenue scale and device flow direction, especially when public reporting was thin. These are illustrative examples only, and many other public and paid sources were also used for data collection, validation, and research clarification.
Primary Interviews and Surveys
Primary work focused on speaking with distributors, procurement and materials teams, operating room staff, and clinical decision makers who influence product choice and ordering patterns, which is where pricing and mix assumptions become clear. Since this is a single-country market, the checks were designed to reflect differences between large emirate level hospital systems and smaller private facilities, then we re-tested assumptions on procedure mix, brand switching, and typical discounting. Inputs from these discussions were used to confirm adoption of minimally invasive tools, the split of disposable versus reusable usage, and realistic replacement cycles for frequently used instruments.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 38% | CXOs: 12% | |
| Mid tier: 44% | Functional/Unit leaders: 40% | |
| Smaller Players: 18% | Managers: 48% |
Market-Sizing & Forecasting
Market sizing was built using a top-down approach where the UAE surgical demand pool was reconstructed from procedure volumes, site of care split, and device intensity per procedure, then translated into value using typical selling price bands. Once the first pass totals were formed, selective bottom-up checks were used to keep the numbers realistic, mainly through distributor channel checks, sampled average selling price (ASP) by device group, and a limited roll-up of visible supplier revenue exposure in the UAE.
A few practical inputs that mattered most in this market were annual surgical procedure growth, share of minimally invasive surgeries (which shifts laparoscopic and access device demand), mix of public versus private hospital procurement behavior, typical tender discount ranges, and the disposable versus reusable split for wound closure and handheld tools. Forecasting used scenario analysis with a simple multivariate regression layer, where procedure growth, capacity additions, and pricing movement assumptions were varied, then aligned with what primary respondents viewed as achievable over the forecast window. When a bottom-up signal was missing for a smaller product pocket, we used proxy ASP bands and utilization rates, then adjusted the result after re-checking with respondents who sit close to ordering decisions.
Data Validation & Update Cycle
Model outputs were checked against independent signals, including procedure growth direction, import trend patterns, and whether the implied per-procedure device value looked reasonable for the UAE care mix. Variances were reviewed in steps, first by comparing each product group to its own history and then by checking whether the total market implied unrealistic pricing or sudden shifts in device intensity. If a number moved beyond what the inputs could explain, respondents were re-contacted to confirm whether the change was real or a modeling artifact.
Before sign-off, a separate analyst review is done to confirm that assumptions are consistent across device groups and that currency conversions and price progression logic are applied the same way throughout the model. The report is refreshed annually, and interim updates are made when material events occur, such as regulatory shifts, major tender cycles, or abrupt changes in procedure volumes. Right before delivery, we run a last pass to ensure the most recent public updates and interview learnings are reflected.
Â鶹ÊÓƵ's UAE General Surgical Devices Market Size Compared Against Other Published Estimates
Published market values for UAE general surgical devices can look far apart, even when the topic name seems the same, because scope boundaries and pricing treatment vary more than most readers expect. Differences often come from whether the estimate is closer to manufacturer revenue versus hospital spend, how disposables are counted, and whether the base year reflects recent tender pricing.
In a refresh-led check, the spread typically increases when older FX rates are held constant, when ASPs are projected using broad medical inflation instead of device specific discount cycles, or when validation is done without reconciling procedure volumes to device intensity. The model here places extra weight on re-checking ASP bands after tender seasons and on converting AED to USD using the base-year average rate, and those update steps are what keep Â鶹ÊÓƵ aligned to a repeatable demand pool rather than a one-time price snapshot.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Â鶹ÊÓƵ | USD 0.42 B (2024) | |
| Global Research Publisher A | USD 0.42 B (2024) | Uses a similar base year but appears to bundle a wider set of surgical tools, including adjacent equipment categories, which can blur the boundary of what is counted as a general surgical device revenue line. |
| Industry Databook B | USD 0.09 B (2024) | Tracks a narrower surgical equipment basket with fewer product groups, so large parts of wound closure, access devices, and several general surgery consumables are not fully captured in the total. |
Across the three figures, the main takeaway is that scope and pricing timing drive most of the gap, not just growth expectations. When device groups are consistently included, ASPs are updated around tender behavior, and currency conversion is handled at a clear base-year average, the resulting market size stays easier to trace, review, and update year after year.
Key Questions Answered in the Report
What is the current UAE general surgical devices market size?
The UAE general surgical devices market is projected to register a CAGR of 6.11% during the forecast period (2026-2031)
Who are the key players in UAE general surgical devices market?
Smith + Nephew, Olympus Corporations, Stryker Corporation, Medtronic PLC and B. Braun SE are the major companies operating in the UAE general surgical devices market.
What years does this UAE general surgical devices market cover?
The report covers the UAE general surgical devices market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the United Arab Emirates General Surgical Devices Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.
Page last updated on:
